Jae W Lee

13PUBLICATIONS
139CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 14, 2026
Clinical, genomic, and spatial transcriptomic features of pancreatic adenosquamous carcinoma support subtype-specific therapeutic strategies.

|May 05, 2026
Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic Cancer.

|Jan 27, 2026
Computational Modeling of Cellular Influence Delineates Functionally Relevant and Distinct Cellular Neighborhoods in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.

Yeonju Cho, Jae W Lee, Sarah M Shin

|Jan 12, 2026
Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses.

Dimitrios N Sidiropoulos, Zhehao Zhang, Jennifer N Durham

|Jan 12, 2026
A Randomized Phase II Study: CRS207/GVAX plus Anti-PD-1 and Anti-CTLA4 Recruits Mesothelin- and mKRAS-Specific T Cells into PDAC.

Katherine M Bever, Amanda L Huff, Ludmila Danilova

|Dec 03, 2024
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma.

Daniel J Zabransky, Emma Kartalia, Jae W Lee

Pageof 3

Frequent Collaborators

7 joint publications

Elizabeth M Jaffee

5 joint publications

Elana J Fertig

4 joint publications

Won Jin Ho

4 joint publications

Sarah M Shin